3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
5
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
29
Uterine Cervical Neoplasms
23
Endometrial Neoplasms
14
Breast Neoplasms
10
Neoplasms
8
Uterine Cervical Dysplasia
5
Carcinoma, Ovarian Epithelial
5
Peritoneal Neoplasms
4
Papillomavirus Infections
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Disease
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Primary Ovarian Insufficiency
2
Ovarian Diseases
2
Melanoma
2
Leukemia
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Hyperplasia
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Interventions
pembrolizumab
3
Biopsy
2
Aminolevulinic Acid
2
pertuzumab
1
osimertinib
1
liposomal doxorubicin
1
cobimetinib
1
cemiplimab
1
cc-486
1
Trastuzumab
1
Tissue Banks
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Solutions
1
Red Light
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Observation
1
Molecular Diagnostic Techniques
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Isotretinoin
1
Interleukin-2
1
Interferon-alpha
1
Injections
1
Immunotherapy
1
Immunohistochemistry
1
IT-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled